Published in Cancer Epidemiol Biomarkers Prev on October 01, 2007
Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08
Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med (2009) 2.84
Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer (2011) 2.01
Predictors of colorectal cancer following a negative colonoscopy in the Medicare population. Dig Dis Sci (2011) 1.62
Self-report versus medical records for assessing cancer-preventive services delivery. Cancer Epidemiol Biomarkers Prev (2008) 1.49
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
Overuse of colonoscopy for colorectal cancer screening and surveillance. J Gen Intern Med (2014) 1.15
Influence of primary care use on population delivery of colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Accuracy of administrative claims data for polypectomy. CMAJ (2011) 1.02
Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities. J Gen Intern Med (2008) 0.95
Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev (2009) 0.94
Do diagnostic and treatment delays for colorectal cancer increase risk of death? Cancer Causes Control (2013) 0.92
Validation of self-reported colorectal cancer screening behaviors among Appalachian residents. Public Health Nurs (2013) 0.92
U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries. J Womens Health (Larchmt) (2013) 0.91
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90
Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol (2013) 0.88
Missed opportunities: racial and neighborhood socioeconomic disparities in emergency colorectal cancer diagnosis and surgery. BMC Cancer (2014) 0.86
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86
Comparing patient and endoscopist perceptions of the colonoscopy indication. Can J Gastroenterol (2010) 0.85
Screening rates for colorectal cancer in Canada: a cross-sectional study. CMAJ Open (2015) 0.85
Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program. Am J Gastroenterol (2015) 0.84
Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer (2014) 0.83
Measurement of colorectal cancer test use with medical claims data in a safety-net health system. Am J Med Sci (2013) 0.83
Predictors of serious complications associated with lower gastrointestinal endoscopy in a major city-wide health region. Can J Gastroenterol (2010) 0.83
Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. EGEMS (Wash DC) (2015) 0.83
Diverticulosis and the risk of interval colorectal cancer. Dig Dis Sci (2014) 0.81
Validation of administrative data sources for endoscopy utilization in colorectal cancer diagnosis. BMC Health Serv Res (2012) 0.81
Different screening definitions have little impact on polypectomy rate estimates. Can J Gastroenterol (2012) 0.81
Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study. BMC Gastroenterol (2012) 0.80
Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection. AIDS Care (2013) 0.80
Accuracy of self-reported reason for colorectal cancer testing. Cancer Epidemiol Biomarkers Prev (2010) 0.78
Physician visits and colorectal cancer testing among Medicare enrollees in North Carolina and South Carolina, 2005. Prev Chronic Dis (2011) 0.78
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50. Prev Med Rep (2016) 0.77
Concordance Between Clinical Diagnosis and Medicare Claims of Depression Among Older Primary Care Patients. Am J Geriatr Psychiatry (2014) 0.77
Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res (2015) 0.76
The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data. BMC Health Serv Res (2016) 0.75
Adverse events Following Computed Tomographic Colonography compared to Optical Colonoscopy in the Elderly. Prev Med Rep (2014) 0.75
Utilization of surveillance after polypectomy in the medicare population--a cohort study. PLoS One (2014) 0.75
Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010. Prev Chronic Dis (2015) 0.75
Validation of colonoscopic findings from a structured endoscopic documentation database against manually collected medical records data. Surg Endosc (2015) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Variations in morbidity after radical prostatectomy. N Engl J Med (2002) 7.26
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 6.42
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84
Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.65
Association of numeracy and diabetes control. Ann Intern Med (2008) 5.08
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
Is this patient clinically depressed? JAMA (2002) 5.03
Assessing comorbidity using claims data: an overview. Med Care (2002) 4.94
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med (2008) 4.55
Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49
Use of SEER-Medicare data for measuring cancer surgery. Med Care (2002) 4.27
Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA (2004) 4.16
Studying radiation therapy using SEER-Medicare-linked data. Med Care (2002) 4.13
An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992-2004. Am J Epidemiol (2008) 3.86
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80
Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst (2004) 3.74
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care (2002) 3.57
Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45
Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med (2003) 3.39
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care (2002) 3.36
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst (2006) 3.19
Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry (2002) 3.15
Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med (2002) 3.11
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA (2002) 3.11
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care (2006) 3.08
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities. J Clin Epidemiol (2003) 2.94
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77
International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA (2009) 2.64
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med (2003) 2.56
In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care (2006) 2.53
Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst (2003) 2.52
Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev (2009) 2.46
Development and validation of the Diabetes Numeracy Test (DNT). BMC Health Serv Res (2008) 2.42
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med (2006) 2.31
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Identifying cancer relapse using SEER-Medicare data. Med Care (2002) 2.28
Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med (2007) 2.26
How to decide whether a clinical practice guideline is trustworthy. JAMA (2013) 2.24
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med (2003) 2.22
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc (2002) 2.20
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut (2013) 2.17
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med (2008) 2.10
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst (2005) 2.08
MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol (2002) 2.07
Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med (2007) 2.07
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof (2013) 2.02
The relationship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ (2004) 2.02
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst (2006) 2.01
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol (2005) 2.00
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
The Spoken Knowledge in Low Literacy in Diabetes scale: a diabetes knowledge scale for vulnerable patients. Diabetes Educ (2005) 1.97
Estimating patient time costs associated with colorectal cancer care. Med Care (2005) 1.94
Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc (2009) 1.94
Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. J Am Coll Surg (2009) 1.94
New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA (2011) 1.88
Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment. Cancer Epidemiol Biomarkers Prev (2009) 1.88
Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials. Diabetes Care (2009) 1.88
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol (2012) 1.81
Drug treatment of hyperlipidemia in women. JAMA (2004) 1.76
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care (2009) 1.76
Patient time requirements for screening colonoscopy. Am J Gastroenterol (2007) 1.74
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.72
Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care (2005) 1.71